Risk factors for extended espectrum beta-lactamase producer E.coli bacteremia from urinary origin;Factores predictores de infección urinaria bacteriémica por Escherichia coli productor de betalactamasas de espectro extendido

Medicina Clinica

Volumn 134, Issue 9, 2010, Pages 392-395

  Velasco Arribas, María ^a   Barrena Puerta, Ruth ^a   Asenjo Mota, Ángel ^a   Valverde Cánovas, José F ^a   Delgado Iribarren, Alberto ^a   Losa García, Juan E ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

Author keywords

Bloodstream infection; Extended spectrum beta lactamase E. coli; Urinary tract infection

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE;

AGED; ARTICLE; BACTEREMIA; BLOODSTREAM INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DATA COLLECTION METHOD; ESCHERICHIA COLI; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; MALE; NURSING HOME; RISK FACTOR; URINARY TRACT DISEASE; URINARY TRACT INFECTION;

AGED; BACTEREMIA; BETA-LACTAMASES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; URINARY TRACT INFECTIONS;

EID: 77949912658     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2009.10.041     Document Type: Article

References (10)

1. Oteo J., Navarro C., Cercenado E., Delgado-Iribarren A., Wilhelmi I., Orden B., et al. Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J Clin Microbiol. 44 (2006) 2359-2366
2. Rodriguez-Bano J., and Paterson D.L. A change in the epidemiology of infections due to extended-spectrum beta-lactamase-producing organisms. Clin Infect Dis. 42 (2006) 935-937
3. Skippen I., Shemko M., Turton J., Kaufmann M.E., Palmer C., and Shetty N. Epidemiology of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp: A nested case-control study from a tertiary hospital in London. J Hosp Infect. 64 (2006) 115-123
4. Rodríguez-Bano J., Alcala J.C., Cisneros J.M., Grill F., Oliver A., Horcajada J.P., et al. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med 168 (2008) 1897-1902
5. Pena C., Gudiol C., Calatayud L., Tubau F., Domínguez M.A., Pujol M., et al. Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: Factors influencing mortality. J Hosp Infect. 68 (2008) 116-122
6. Calbo E., Romani V., Xercavins M., Gómez L., Vidal C.G., Quintana S., et al. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J Antimicrob Chemother. 57 (2006) 780-783
7. Rodríguez-Bano J., López-Cerero L., Navarro M.D., de Alba P.D., and Pascual A. Faecal carriage of extended-spectrum {beta}-lactamase-producing Escherichia coli: Prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother. 62 (2008) 1142-1149
8. Ortega M., Marco F., Soriano A., Almela M., Martínez J.A., Munoz A., et al. Analysis of 4758 Escherichia coli bacteraemia episodes: Predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J Antimicrob Chemother. 63 (2009) 568-574
9. Velasco M., Horcajada J.P., Mensa J., Moreno-Martínez A., Vila J., Martínez J.A., et al. Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections. Clin Infect Dis 33 (2001) 1682-1686
10. Velasco M, Tolon R, Valverde J, Delgado-Iribarren A, Pavon R, Moreno L. Extended-spectrum beta-lactamase uropathogenic E. coli exhibit a lower presence of virulence factors but a higher invasiveness (resumen L-493). 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, ICAAC, Chicago (Estados Unidos) Sep 2007